Nutritional therapy complications in children with ultra‐short bowel syndrome include growth deficiency but not cholestasis
Open Access
- 6 February 2018
- journal article
- research article
- Published by Wiley in Acta Paediatrica
- Vol. 107 (6) , 1088-1093
Abstract
Aim: Children with ultra‐short bowel syndrome (USBS) have not been extensively studied to date because the condition is rare. The aim of the study was to assess the nutritional status of children with USBS receiving home parenteral nutrition, using citrulline serum concentration and cholestasis.Methods: We studied 17 patients with USBS, with a median age of 6.6 years and median duration of parenteral nutrition of 6.6 years. The study was carried out at The Children's Memorial Health Institute, Warsaw, from January 2014 to January 2015.Results: The median standard deviation score (SDS) was −1.2 for body mass according to chronological age, −1.72 according to height and −0.59 according to height for age. Patients requiring seven days per week parenteral nutrition had a citrulline concentration below 10 μmol/L. Decreased bone‐mineral density was observed in 87% of the patients. Low values of 25‐hydroxyvitamin D were found in 53% of the children. None of the patients had elevated conjugated bilirubin levels above 34.2 μmol/L.Conclusion: Children with USBS were growth deficient according to their chronological age, with frequent abnormal bone mineralisation and vitamin D deficiency. Children requiring parenteral nutrition seven days a week had citrulline concentrations below 10 μmol/L. Cholestasis was not seen.Keywords
Funding Information
- Children's Memorial Health Institute, the Polish Ministry of Science and Higher Education (224/13)
- European Union (POIG.02.01.00-14-059/09)
This publication has 25 references indexed in Scilit:
- Risk of Metabolic Bone Disease is Increased Both during and after Weaning off Parenteral Nutrition in Pediatric Intestinal FailureHormone Research in Paediatrics, 2013
- Ultrashort Bowel Syndrome in ChildrenJournal of Pediatric Gastroenterology and Nutrition, 2013
- Plasma citrulline may be a good marker of intestinal functions in intestinal dysfunctionPediatrics International, 2012
- Teduglutide Reduces Need for Parenteral Support Among Patients With Short Bowel Syndrome With Intestinal FailureGastroenterology, 2012
- Citrulline: pharmacological perspectives and its role as an emerging biomarker in futureFundamental & Clinical Pharmacology, 2012
- Plasma citrulline as marker of bowel adaptation in children with short bowel syndromeLangenbeck's Archives of Surgery, 2011
- Low Serum Citrulline Concentration Correlates With Catheter‐Related Bloodstream Infections in Children With Intestinal FailureJournal of Parenteral and Enteral Nutrition, 2011
- Relationship between serum citrulline levels and progression to parenteral nutrition independence in children with short bowel syndromeJournal of Pediatric Surgery, 2009
- Outcome and Long-Term Growth After Extensive Small Bowel Resection in the Neonatal Period: A Survey of 87 ChildrenEuropean Journal of Pediatric Surgery, 2005
- Serum citrulline levels correlate with enteral tolerance and bowel length in infants with short bowel syndromeThe Journal of Pediatrics, 2005